AzTrials
AzTrials

Deep LearningNCT06751693

Development of a Scoring and Prediction Model for Weaning Success in ARDS Patients Using Ventilation Parameters Combined with Artificial Intelligence and Deep Learning Techniques

An observational study of Deep Learning and Artificial Intelegence, run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to develop an AI-supported scoring model to optimize the weaning processes of ARDS patients from mechanical ventilation. Retrospective analysis will be conducted on the data of 25,000 patients, focusing on ventilator parameters and hemodynamic variables. Read more about this study

Who is it for?
Ages 18 years and older
How many people
25,000 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Dec 2024to 24 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Intubated patients which diagnosed with ARDS and followed up in the ICU for more than 48 hours.

Who may be able to join

  • ARDS diagnosis
  • Aged 18 years and older
  • Intubated and followed by Mechanical ventilation
  • Admission on Intensive care unit
  • Complete data on clinical support and desicion system

Who cannot join

  • Missing data
  • Under 18 years of age
  • Followed by non-ARDS conditions
  • Terminal status

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Bakirkoy Dr Sadi Konuk Research and Training Hospital

    Istanbul

Other trials in Turkey (Türkiye)

About this study

This study aims to develop an AI-supported scoring model to optimize the weaning processes of ARDS patients from mechanical ventilation. Retrospective analysis will be conducted on the data of 25,000 patients, focusing on ventilator parameters and hemodynamic variables. The model will be designed to contribute to clinical decision support systems.

Read the detailed description

The aim of this study is to develop an artificial intelligence and deep learning-supported scoring system using ventilator parameters obtained during the mechanical ventilation process in patients diagnosed with ARDS. This system seeks to predict and optimize the weaning process, facilitating successful liberation from mechanical ventilation.

In this context, our study will analyze data from 25,000 patients obtained from the Metavision system. From this data pool, ARDS patients will be filtered and divided into two groups: those successfully weaned from mechanical ventilation (weaned) and those who were not (non-weaned). The ventilator parameters of both groups, including oxygenation indices, driving pressure, and total mechanical power, will be examined in detail.

The collected data will be analyzed using artificial intelligence and deep learning algorithms to develop a scoring system capable of predicting patients' weaning processes. This system is designed to guide clinicians in patient management and enhance the success of weaning procedures.

The results of this study aim to contribute to more efficient and safer management of the weaning process for ARDS patients. Furthermore, the implementation of AI-supported scoring systems in intensive care units is expected to promote widespread adoption and improve the quality of patient care.

Keywords
Deep Learning
Medical subject headings
Acute Lung Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06751693
Study groupRoleWhat they receive
WeanedThose successfully weaned from mechanical ventilation
Non-weanedThose who not weaned from mechanical ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Successful Weaning

    The primary outcome of this study will be the successful weaning from mechanical ventilation.

    Measured: 48 hours

Secondary outcomes (1)
  1. Mechanical Ventilatory Parameters

    Determining the impact of mechanical power on patient outcomes.

    Measured: 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2024
  2. Study start10 Dec 2024
  3. Primary completion24 Dec 2024
  4. Study completion24 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
25,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06751693
Sponsor's protocol ID
2024-12-07
Status last verified
Dec 2024
First submitted
11 Dec 2024
Last updated
30 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Deep Learning and Artificial Intelegence, run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Successful Weaning (time frame: 48 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2024; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in